Biotech companies that will lead the next decade wont just have better science, theyll have superior operating models, writes ...

JAM Admit Card 2026 release date has been postponed. The revised date of release of the hall ticket will be announced soon.  | Competitive Exams ...

Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

AI is no longer a distant concept; it is reshaping industries today. For pharmaceutical companies, the question is clear: how ...

Manufacturing, tech-related projects take top honors in Business Facilities' annual awards, which recognize corporate ...

Allucent has strategically added executives to its C-suite and is deploying artificial intelligence tools to help small and ...

US biotech Aktis Oncology has filed IPO documents with the Securities and Exchange Commission (SEC), in what could be the ...

Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) application for SKB105 (also known as CR-003), an ...

CR-001 IND cleared by U.S. FDA; Phase 1/2 ASCEND global clinical trial to evaluate CR-001 in first-line and previously ...